Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds.
Eike-Christian WamhoffLarance RonsardJared FeldmanGrant A KnappeBlake M HauserAnna RomanovJames Brett CaseShilpa SanapalaEvan C LamKerri J St DenisJulie BoucauAmy K BarczakAlejandro B BalazsMichael S. DiamondAaron G SchmidtDaniel LingwoodMark BathePublished in: Nature communications (2024)
Protein-based virus-like particles (P-VLPs) are commonly used to spatially organize antigens and enhance humoral immunity through multivalent antigen display. However, P-VLPs are thymus-dependent antigens that are themselves immunogenic and can induce B cell responses that may neutralize the platform. Here, we investigate thymus-independent DNA origami as an alternative material for multivalent antigen display using the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, the primary target of neutralizing antibody responses. Sequential immunization of mice with DNA-based VLPs (DNA-VLPs) elicits protective neutralizing antibodies to SARS-CoV-2 in a manner that depends on the valency of the antigen displayed and on T cell help. Importantly, the immune sera do not contain boosted, class-switched antibodies against the DNA scaffold, in contrast to P-VLPs that elicit strong B cell memory against both the target antigen and the scaffold. Thus, DNA-VLPs enhance target antigen immunogenicity without generating scaffold-directed immunity and thereby offer an important alternative material for particulate vaccine design.
Keyphrases
- circulating tumor
- sars cov
- cell free
- single molecule
- tissue engineering
- nucleic acid
- binding protein
- type diabetes
- magnetic resonance
- respiratory syndrome coronavirus
- circulating tumor cells
- working memory
- computed tomography
- transcription factor
- high throughput
- small molecule
- dengue virus
- coronavirus disease
- protein protein